GDG. S. Desai

G. S. Desai

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article


G. S. Desai has a total of 35 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

    • 1 March 2016
      • Vol. 54  (3) , 180-6

    Production and characterization of monoclonal antibodies to Newcastle Disease Virus.

    by G Ravi Kumar, Shikha Saxena, A P Sahoo, Uttara Chaturvedi, Satish Kumar, Lakshman Santra, G S Desai, Lakshyaveer Singh, Ashok K Tiwari

    Newcastle Disease (ND) is one of the major causes of economic loss in the poultry industry. Newcastle Disease Virus (NDV) is a single-stranded, negative-sense enveloped RNA virus (Fam. Paramyxoviridae; Order Mononegavirales). In the present study three monoclonal antibodies (MAbs) were produced by polyethyleneglycol (PEG)-mediated fusion of lymphocytes sensitized to NDV Bareilly strain and myeloma cells. NDV possesses ability to agglutinate erythrocytes of avian species. All the three MAbs designated as 2H7, 3E9 and 3G6 caused hemagglutination inhibition of NDV by specifically binding to NDV. The reactivity for all the 3 MAbs on indirect ELISA was found to be significantly higher than the antibody and antigen controls. On flowcytometry of HeLa cells infected with NDV using the MAbs as primary antibodies, there was a significant difference in the percentage of cells showing positive fluorescence compared to the mock control. One of the MAbs (3E9) was found to react with hemagglutinin-neuraminidase (HN) protein on western blot.

    • 1 October 2014
      • Vol. 52  (10) , 935-42

    Development of dog mammary tumor xenograft in immunosuppressed Swiss albino mice.

    by R S Rajmani, Prafull Kumar Singh, Sanjay Kumar, G Ravi Kumar, Aditya P Sahoo, Lakshman Santra, Shikha Saxena, Lakshya Veer Singh, Uttara Chaturvedi, Lovleen Saxena, et al.

    Development and study of dog mammary tumour xenograft in immunosuppressed Swiss Albino Mice adds a new dimension in cancer research as dog tumors have many similarities with human tumors regarding progression, histopathology, molecular mechanism, immune response and therapy. Failure of the immune system to recognize and eliminate cancer cells leads to cancer progression and the fight between immune cells and cancer cells has a great role in understanding the mechanism of cancer progression and elimination. Rejection and acceptance of tumour xenograft depends on efficiency of CD4+, CD8+ and NK cell populations. In the present investigation, dog mammary tumor xenograft in cyclosporine-A and gamma-irradiated, immunosuppressed Swiss Albino mice was developed and the immune cell status of graft accepted and rejected mice was assessed. It was observed that all the major immune cells (CD4+, CD8+ and NK cells) play an equal role in tumour rejection.

  • Open Access

    Evaluation and comparison of the constitutive expression levels of Toll-like receptors 2, 3 and 7 in the peripheral blood mononuclear cells of Tharparkar and crossbred cattle

    by Lakshya Veer Singh, Shikha Saxena, Smita Gupta, Shishir Kumar Gupta, G. Ravi Kumar, G. S. Desai, Aditya Prasad Sahoo, D. R. Harish, A. K. Tiwari


    • 1 September 2012
      • Vol. 50  (9) , 618-24

    In vitro expression studies of non structural 1 protein of Canine Parvo virus 2 by polyclonal antiserum raised against CPV2-NS1 protein expressed in Escherichia coli as an antigen.

    by G Ravi Kumar, Shikha Saxena, Lovleen Saxena, Uttara Chaturvedi, Lakshman Santra, Rajiv Kumar, Aditya Prasad Sahoo, Rajmani, Aswani Kumar, G S Desai, et al.

    The canine Parvovirus 2, non-structural 1 (NS1) is a novel candidate tumor suppressor gene. To confirm the expression of the NS1 in HeLa cells after transfection there was a need to raise antiserum against CPV2- NS1. Therefore, this study was carried out to express and purify the recombinant NS1 (rNS1), and characterize the polyclonal serum. CPV2-NS1, complete coding sequence (CDS) was amplified, cloned in pET32a+ and expressed in BL21 (DE3) (pLysS). SDS-PAGE analysis revealed that the expression of the recombinant protein was maximum when induced with 1.5 mM IPTG. The 6 x His tagged fusion protein was purified on Ni-NTA resin under denaturing conditions and confirmed by western blot using CPV2 specific antiserum. The rabbits were immunized with the purified rNS1 to raise anti-NS1 polyclonal antiserum. The polyclonal serum was tested for specificity and used for confirming the expression of NS1 in HeLa transfected with pcDNA.cpv2.ns1 by indirect fluorescent antibody test (IFAT), flow cytometry and western blot. The polyclonal antiserum against NS1 could be very useful to establish functional in vitro assays to explore role of NS1 in cancer therapeutics.


  • 5'-UTR-based phylogenetic analysis of Classical swine fever virus isolates from India

    by G. Desai, A. Sharma, R. Kataria, N. Barman, A. Tiwari

    5'-UTR-based phylogenetic analysis of Classical swine fever virus isolates from India


  • Sequence Analysis of the S10 Gene of Six Bluetongue Virus Isolates from India

    by G. S. Desai, M. Hosamane, R. S. Kataria, S. S. Patil, K. Prabhudas, R. K. Singh, V. Bhanuprakash, B. Mondal

    Bluetongue Virus (BTV) genome segment 10 (S10)‐based phylogenetic studies are important in understanding the BTV evolution. S10 gene‐based phylogenetic analysis grouped six different BTV isolates (BTV serotype 1, 18 and 23) from India in subclade A1 and showed closer relationship with BT viruses from Mediterranean Basin. Indian BTV serotypes 18 and 23 formed a single cluster distinct from BTV serotype 1 isolates and were evolved from BTV from China, Indonesia and Australia. The overall S10 sequences of BTV isolates from India were largely conserved (>95.7% homology) and were distinct from other BT viruses of the world.